How to Register

Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan

MOLECULAR GENETICS AND METABOLISM REPORTS Volume 15 Page 55-63 published_at 2018-06

アクセス数 : 1436 件

ダウンロード数 : 0 件

今月のアクセス数 : 62 件

今月のダウンロード数 : 0 件

この文献の参照には次のURLをご利用ください : https://ir.lib.shimane-u.ac.jp/53167

Title	Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan
Creator	YAMADA Kenji Shiraishi Hideaki Oki Eishin Ishige Mika Fukao Toshiyuki Hamada Yusuke Sakai Norio Ochi Fumihiro Watanabe Asami Kawakami Sanae Kuzume Kazuyo Watanabe Kenji Sameshima Koji Nakamagoe Kiyotaka Tamaoka Akira Asahina Naoko Yokoshiki Saki Miyakoshi Takashi Ono Kota Oba Koji Isoe Toshiyuki Hayashi Hiroshi Yamaguchi Seiji Sato Norihiro
Source Title	MOLECULAR GENETICS AND METABOLISM REPORTS
Volume	15
Start Page	55
End Page	63
Journal Identifire	ISSN 2214-4269
Subjects	Bezafibrate; Fatty acid oxidation disorders (FAODs); Very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency; Carnitine palmitoyltransferase-II (CPT-2) deficiency; Clinical trial ( Other)
Language	eng
Resource Type	journal article
Publisher	ELSEVIER SCIENCE BV
Date of Issued	2018-06
Access Rights	metadata only access
Relation	[DOI] 10.1016/j.ymgmr.2018.02.003 [PMID] 29552494
Remark	This study was supported by The multicenter clinical trial of the efficacy and safety of bezafibrate for mitochondrial fatty acid beta-oxidation disorders (Grant Number, 16lk0103005h0005) from the Japan Agency for Medical Research and Development (AMED).